Sviluppa Binding Protein food-grade prodotte per fermentazione di precisione che neutralizzano metaboliti nocivi nell'intestino.
| Date | Round | Amount |
|---|---|---|
| Jan 2026 | Series B Danish Bactolife raised over €30 million in a Series B led by Cross Border Impact Ventures and EIFO to move from R&D to commercialization, with its first US launch in 2026. | $34.8M |
| Aug 2023 | Series A Copenhagen-based Bactolife raised a EUR30M Series A led by ATHOS, with the Gates Foundation and Novo Holdings. | $32.4M |
| Aug 2022 | Grant Copenhagen gut-health biotech Bactolife secured 5M dollars from the Bill & Melinda Gates Foundation to develop its Binding Proteins against gut infections. | $5M |